Clinical Trials Logo

Filter by:
NCT ID: NCT04627298 Completed - Clinical trials for Human Papillomavirus

Normalizing HPV Vaccination in Preteens With a Serious Video Game

Start date: July 9, 2015
Phase: N/A
Study type: Interventional

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States and causes genital warts and cancers in both females and males. Vaccination against HPV is recommended for routine use in those aged 11-12 years old, yet is underutilized. The study's premise is that preteens are relevant decision makers who can be motivated to initiate and complete the HPV vaccine series (assuming parental consent and provider recommendation). This study evaluates a serious video game to engage preteens in the decision to pursue HPV vaccination. The hypothesis is that preteens who are assigned to the video game will be more likely to initiate and complete HPV vaccination than preteens who are not assigned to the video game.

NCT ID: NCT04627077 Completed - Neoplasms Clinical Trials

Livestrong Cancer Institutes' Patient Reported Outcomes Study

LCI PROs
Start date: January 22, 2018
Phase:
Study type: Observational

The goal of this study will be to collect baseline patient reported outcome measures at the Livestrong Cancer Institutes (LCI) with the goal of improving quality care and to inform decision making by patients, providers, and researchers for future LCI initiatives.

NCT ID: NCT04627038 Completed - Osteoarthritis Clinical Trials

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis

Start date: November 12, 2020
Phase: Phase 2
Study type: Interventional

This study is being done to test the safety and efficacy of LY3556050 for the treatment of osteoarthritis pain. This trial is part of the chronic pain master protocol, H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.

NCT ID: NCT04627025 Completed - Clinical trials for Short Bowel Syndrome

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

STARS
Start date: January 26, 2021
Phase: Phase 3
Study type: Interventional

The primary objective of the trial is the confirmation of the efficacy of apraglutide to evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support dependency.

NCT ID: NCT04626895 Completed - Breast Cancer Clinical Trials

Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers

Start date: June 4, 2019
Phase: N/A
Study type: Interventional

This study will measure the efficacy of scalp cooling with the Paxman Scalp Cooling (PSC) device in a diverse patient population with success measured as prevention of more than 50% hair loss during chemotherapy. We propose that scalp cooling has distinct efficacy in participants with black or ethnic-minority hair types due to differences in textures, hair thickness. This study will examine the success rate of scalp cooling in black patients receiving chemotherapy for breast or gynecological cancer.

NCT ID: NCT04626804 Completed - Depression Clinical Trials

Remember Stuff: A Dyadic-focused Technology to Support Persons With Alzheimer's Disease in the Community

R/S
Start date: October 27, 2020
Phase: N/A
Study type: Interventional

Test the usability, perceptions and acceptability of a computer monitor for participant diagnosed with ADRD and their caregiver who will program the applications specifically for each individual to help them remember activities of daily living. Goal is to keep participants in their homes longer and delay the need for institutional care

NCT ID: NCT04626778 Completed - Healthy Clinical Trials

Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria in Saliva and Bioaerosol Contamination

Start date: October 8, 2020
Phase: Phase 2
Study type: Interventional

To evaluate the anti-bacterial, pre-procedural, clinical efficacy of Peroxyl mouthwash (1.5% hydrogen peroxide) in saliva and the reduction of bioaerosol contamination as compared to a matching placebo mouthwash (0.0% hydrogen peroxide)

NCT ID: NCT04626453 Completed - Clinical trials for Diabetes Mellitus, Type 2

Oxygenation Changes After 2-month Exercise in Sedentary Older Adults With Diabetes

Start date: October 29, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to determine the physiological evidence of how muscular and cerebral oxygenation changes link to fatigue, physical, and cognitive performance after moderate-intensity exercise in sedentary older adults with type 2 diabetes.

NCT ID: NCT04626310 Completed - Clinical trials for Borderline Personality Disorder

Mapping Aspects of Psychotherapy in Dialectical Behavior Therapy

MAP-DBT
Start date: October 26, 2020
Phase: N/A
Study type: Interventional

Although dialectical behavior therapy (DBT) skills training is effective in the treatment of borderline personality disorder, it contains four skills modules and there is little research to guide their modular application. This study compares the unique effects of two distinct DBT skills training modules, relative to a non-DBT therapy group for adults with borderline personality disorder. Using innovative laboratory-based assessment methods, the proposed study will examine the effects of these conditions on emotional responding and interpersonal functioning, as well as clinical outcomes.

NCT ID: NCT04626297 Completed - Atopic Dermatitis Clinical Trials

A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

Start date: November 17, 2020
Phase: Phase 3
Study type: Interventional

The reason for this study is to assess the impact of lebrikizumab on vaccine immune response in adult participants with moderate to severe atopic dermatitis (AD).